Infertile mice produced sperm and fathered offspring after transplantation of sperm progenitor cells grown in laboratory culture, according to research published in the online edition of Proceedings of the National Academy of Sciences.
Infertile mice produced sperm and fathered offspring after transplantation of sperm progenitor cells grown in laboratory culture, according to research published in the online edition of Proceedings of the National Academy of Sciences.
Researchers successfully developed a culture medium with the precise combination of cellular growth factors needed for spermatogonial stem cells to reproduce themselves outside the body. These stem cells were implanted into infertile mice. The mice produced sperm and fathered offspring genetically related to the donor mice.
If the culture media is manipulated, the researchers may be able to induce spermatogonial cells to develop into sperm cells for the fertilization of eggs, said senior author Ralph L. Brinster, VMD, PhD, of the University of Pennsylvania School of Veterinary Medicine in Philadelphia.
"This finding is likely to be applicable to humans," Dr. Brinster said.
Spermatogonial stem cells could be cultured to increase numbers, frozen, and reimplanted at a later date in those males who lose their fertility from chemotherapy, spinal cord injury, Parkinson's disease, or heart disease.
The research was funded in part by the National Institute of Child Health and Human Development.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.